These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27184479)

  • 1. Frequent PIK3CA-activating mutations in hidradenoma papilliferums.
    Liau JY; Lan J; Hong JB; Tsai JH; Kuo KT; Chu CY; Sheen YS; Huang WC
    Hum Pathol; 2016 Sep; 55():57-62. PubMed ID: 27184479
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Goto K; Maeda D; Kudo-Asabe Y; Hibiya T; Hayashi A; Fukayama M; Ohashi K; Goto A
    J Clin Pathol; 2017 May; 70(5):424-427. PubMed ID: 27742746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenoma.
    Pfarr N; Sinn HP; Klauschen F; Flechtenmacher C; Bockmayr M; Ridinger K; von Winterfeld M; Warth A; Lorenz K; Budczies J; Penzel R; Lennerz JK; Endris V; Weichert W; Stenzinger A
    Genes Chromosomes Cancer; 2016 Feb; 55(2):113-9. PubMed ID: 26493284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Several genotypes, one phenotype: PIK3CA/AKT1 mutation-negative hidradenoma papilliferum show genetic lesions in other components of the signalling network.
    Pfarr N; Allgäuer M; Steiger K; Weichert W; Schirmacher P; Noske A; Stenzinger A
    Pathology; 2019 Jun; 51(4):362-368. PubMed ID: 31010589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AKT1 E17K in Colorectal Carcinoma Is Associated with BRAF V600E but Not MSI-H Status: A Clinicopathologic Comparison to PIK3CA Helical and Kinase Domain Mutants.
    Hechtman JF; Sadowska J; Huse JT; Borsu L; Yaeger R; Shia J; Vakiani E; Ladanyi M; Arcila ME
    Mol Cancer Res; 2015 Jun; 13(6):1003-8. PubMed ID: 25714871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular alterations in lesions of anogenital mammary-like glands and their mammary counterparts including hidradenoma papilliferum, intraductal papilloma, fibroadenoma and phyllodes tumor.
    Konstantinova AM; Vanecek T; Martinek P; Kyrpychova L; Spagnolo DV; Stewart CJR; Portelli F; Michal M; Kazakov DV
    Ann Diagn Pathol; 2017 Jun; 28():12-18. PubMed ID: 28648934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vulvar hidradenoma papilliferum (HP) is located on the sites of mammary-like anogenital glands (MLAGs): Analysis of the photographs of 52 tumors.
    El-Khoury J; Renald MH; Plantier F; Avril MF; Moyal-Barracco M
    J Am Acad Dermatol; 2016 Aug; 75(2):380-4. PubMed ID: 26944596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent PIK3CA activating mutations in nipple adenomas.
    Liau JY; Lee YH; Tsai JH; Yuan CT; Chu CY; Hong JB; Sheen YS
    Histopathology; 2017 Jan; 70(2):195-202. PubMed ID: 27441415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidradenoma Papilliferum: A Clinicopathologic Study of 264 Tumors From 261 Patients, With Emphasis on Mammary-Type Alterations.
    Konstantinova AM; Michal M; Kacerovska D; Spagnolo DV; Stewart CJ; Kutzner H; Zelger B; Plaza JA; Denisjuk N; Hejda V; Shelekhova K; Bisceglia M; Danis D; Zamecnik M; Kerl K; Guenova E; Kazakov DV
    Am J Dermatopathol; 2016 Aug; 38(8):598-607. PubMed ID: 26863059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin.
    Liau JY; Tsai JH; Huang WC; Lan J; Hong JB; Yuan CT
    Hum Pathol; 2018 Mar; 73():59-65. PubMed ID: 29241739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast.
    Troxell ML; Levine J; Beadling C; Warrick A; Dunlap J; Presnell A; Patterson J; Shukla A; Olson NR; Heinrich MC; Corless CL
    Mod Pathol; 2010 Jan; 23(1):27-37. PubMed ID: 19898424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hidradenoma papilliferum of the vulva: case report and review of literature.
    Duhan N; Kalra R; Singh S; Rajotia N
    Arch Gynecol Obstet; 2011 Oct; 284(4):1015-7. PubMed ID: 21132312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer.
    Juanpere N; Agell L; Lorenzo M; de Muga S; López-Vilaró L; Murillo R; Mojal S; Serrano S; Lorente JA; Lloreta J; Hernández S
    Hum Pathol; 2012 Oct; 43(10):1573-82. PubMed ID: 22417847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hidradenoma papilliferum of the vulva in association with an anogenital mammary-like gland.
    Kurashige Y; Kishida K; Kurashige K; Minemura T; Nagatani T
    J Dermatol; 2014 May; 41(5):411-3. PubMed ID: 24617304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survey of KRAS, BRAF and PIK3CA mutational status in 209 consecutive Italian colorectal cancer patients.
    Bozzao C; Varvara D; Piglionica M; Bagnulo R; Forte G; Patruno M; Russo S; Piscitelli D; Stella A; Resta N
    Int J Biol Markers; 2012 Dec; 27(4):e366-74. PubMed ID: 23125007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma.
    Lubin D; Toorens E; Zhang PJ; Jaffer S; Baraban E; Bleiweiss IJ; Nayak A
    Am J Surg Pathol; 2019 Jul; 43(7):1005-1013. PubMed ID: 31094929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of Selected BRCA1, BRCA2, and PIK3CA Mutations in Benign and Malignant Lesions of Anogenital Mammary-Like Glands.
    Konstantinova AM; Shelekhova KV; Imyanitov EN; Iyevleva A; Kacerovska D; Michal M; Kazakov DV
    Am J Dermatopathol; 2017 May; 39(5):358-362. PubMed ID: 28291131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile papillomatosis of the breast (Swiss cheese disease) has frequent associations with PIK3CA and/or AKT1 mutations.
    Guillet C; Rechsteiner M; Bellini E; Choschzick M; Moskovszky L; Dedes K; Papassotiropoulos B; Varga Z
    Hum Pathol; 2020 Apr; 98():64-73. PubMed ID: 32088208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer.
    Reggiani Bonetti L; Barresi V; Bettelli S; Caprera C; Manfredini S; Maiorana A
    Hum Pathol; 2017 Apr; 62():91-98. PubMed ID: 28025078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A composite neoplastic lesion of the vulva with mixed features of fibroadenoma and hidradenoma papilliferum combined with pseudoangiomatous stromal hyperplasia containing multinucleated giant cells.
    Konstantinova AM; Kacerovska D; Michal M; Kazakov DV
    Am J Dermatopathol; 2014 Oct; 36(10):e171-4. PubMed ID: 23503319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.